title: [Paraneoplastic pemphigus in chronic lymphocytic leukemia].
abstract: BACKGROUND
  Paraneoplastic pemphigus is an autoimmune bullous disease described by precise clinical, histological and immunological features presented by Anhalt in 1990. Prognosis is very severe and depends on the associated neoplasia and the gravity of the mucosal damage.
  
  
  METHODS
  Paraneoplastic pemphigus was diagnosed in a 62-year-old man with chronic lymphoid leukemia. The course was favorable up to one-year follow-up after general corticosteroid therapy.
  
  
  CONCLUSIONS
  This case illustrates that paraneoplastic pemphigus can be controlled by general corticosteroids and would suggest the severe prognosis may be improved.
authors.affiliation: Service de Dermatologie, Hôpital Bichat, Paris.
authors.forename: B
authors.initials: B
authors.lastname: Fournier
authors.forename: F
authors.initials: F
authors.lastname: Bouscarat
authors.forename: P
authors.initials: P
authors.lastname: Le Bozec
authors.forename: P
authors.initials: P
authors.lastname: Joly
authors.forename: P
authors.initials: P
authors.lastname: Gardin
authors.forename: M
authors.initials: M
authors.lastname: Grossin
authors.forename: V
authors.initials: V
authors.lastname: Descamps
authors.forename: B
authors.initials: B
authors.lastname: Crickx
authors.forename: S
authors.initials: S
authors.lastname: Belaïch
mesh_terms: D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007150:Immunohistochemistry; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes; D010392:Pemphigus / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D005938:Glucocorticoids; D011241:Prednisone